相关实验视频

Updated: May 9, 2025

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

新出现的非典型临床病理表现免疫媒介性死性肌肉病变 (IMNM)

Michael P Skolka¹, Iago Pinal-Fernandez², Andrew L Mammen²

¹Division of Neuromuscular Medicine, Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.

Neuromuscular disorders : NMD

|May 2, 2025

概括

免疫媒介性死性肌肉病变 (IMNM) 呈现出非典型的症状和病理,具有挑战性的诊断. 识别这些不同的表现是及时免疫治疗和改善这种可治疗的自身免疫疾病的结果的关键.

科学领域:

神经学神经学
免疫学免疫学免疫学
病理学病理学病理学

背景情况:

免疫媒介性死肌病 (IMNM) 是一种严重的自身免疫性疾病.
它通常呈现出快速的肌肉衰弱和升高的肌酸激酶 (CK).
早期诊断和免疫治疗对于更好的患者预后至关重要.

研究的目的:

审查和突出IMNM的非典型的临床和组织病理表现.
强调识别这些变异的重要性,以便及时诊断和治疗.
为了更好地了解这种可治疗肌肉病的多样化表型.

主要方法:

关于IMNM的最新证据的文献综述.
分析非典型的临床表现 (例如,慢性过程,消化不良,眼球膜干扰).
检查扩展的神经病理发现 (例如,管状聚合物,肌纤维细胞病理学).

主要成果:

IMNM可以表现为缓慢渐进的软弱,模仿其他肌肉发育不良.
非典型的特征包括孤立的消化不良,眼球球状体征或无症状的CK高血症.
组织病理学可能会显示纤维亡之外的特征,例如线粒体变化或脂质积累.

结论:

非典型的IMNM表现可能会延迟诊断和治疗.
意识到不同的临床和病理表型是必不可少的.
早期识别有助于及时免疫治疗,改善IMNM患者的治疗结果.

关键词:

非典型的临床和组织病理表现.在HMGCR抗体中.免疫介导的死性肌肉病变.死性自身免疫性肌肉病变 (myopathy) 是一种疾病.在SRP抗体中.

更多相关视频

Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions

Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions

Published on: August 14, 2021

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...